Ionis Pharmaceuticals, Inc.
MODULATORS OF YAP1 EXPRESSION
Last updated:
Abstract:
The present embodiments provide methods, compounds, and compositions useful for inhibiting YAP1 expression, which may be useful for treating, preventing, or ameliorating a cancer associated with YAP1.
Status:
Application
Type:
Utility
Filling date:
31 Jan 2020
Issue date:
29 Apr 2021